The Positive Impacts of Real-World Data on the Challenges Facing the Evolution of Biopharma
The biopharmaceutical industry must access, manage, and analyze Real-World Data (RWD) to generate Real-World Evidence (RWE), but does each company need to build their own in-house capability? Precompetitive collaboration should lead to better, morecost-effective solutions.
